7.2(top 2%)
Impact Factor
7.7(top 2%)
extended IF
96(top 4%)
H-Index
4.6K
authors
3.3K
papers
76K
citations
3.1K
citing journals
47.7K
citing authors

Most Cited Articles of OncoImmunology

TitleYearCitations
Consensus guidelines for the detection of immunogenic cell death2014524
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC2016367
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death2014309
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan2012260
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy2014259
Targeting PD-1/PD-L1 interactions for cancer immunotherapy2012248
IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors2015247
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8 T cells2013239
Role of IL-2 in cancer immunotherapy2016212
TIM3FOXP3 regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer2013193
Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer2016186
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression2015184
Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment2015182
First oncolytic virus approved for melanoma immunotherapy2016181
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer2017177
Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases2016176
Trial watch: Prognostic and predictive value of the immune infiltrate in cancer2012173
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy2015172
Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands2012167
A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab2015166
Trial watch: IDO inhibitors in cancer therapy2014166
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy2012164
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy2012163
Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease2012163
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy2015162